ClinicalTrials.gov
ClinicalTrials.gov Menu

Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01670565
Recruitment Status : Completed
First Posted : August 22, 2012
Last Update Posted : March 16, 2017
Sponsor:
Collaborator:
Human Genome Sciences Inc.
Information provided by (Responsible Party):
Hospital for Special Surgery, New York

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2015
  Actual Study Completion Date : February 2016

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 January 10, 2018
February 9, 2018
2 March 8, 2018
April 5, 2018